Company · CIK 0001595097 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 15, 4:59 pm EDT | Yong BenDirector | 2,000 | $7.84 | $15,683 | 9,383 | −17.6% | 10b5-1 |
| Aug 16, 2026 AForm 4 → | Aug 17, 4:30 pm EDT | Leonardo Viana NicacioChief Medical Officer | 58,333 | — | — | 58,333 | — | |
| Aug 11, 2026 PForm 4 → | Aug 12, 4:30 pm EDT | Nishant C SaxenaChief Business Officer | 2,600 | $9.63 | $25,036 | 77,900 | +3.45% | |
| Aug 7, 2026 SForm 4 → | Aug 10, 4:30 pm EDT | Yuval CohenChief Executive Officer, Director | 17,000 | $10.08 | $171,396 | 157,316 | −9.75% | 10b5-1 |
| Aug 7, 2026 SForm 4 → | Aug 10, 4:30 pm EDT | Sean F. MoranChief Financial Officer | 12,000 | $10.08 | $120,971 | 84,694 | −12.4% | 10b5-1 |
| Jun 10, 2026 SForm 4 → | Jun 11, 4:30 pm EDT | Winston KungDirector | 2,026 | $7.91 | $16,033 | 12,140 | −14.3% | 10b5-1 |
| Jun 10, 2026 SForm 4 → | Jun 11, 4:30 pm EDT | Anne AltmeyerDirector | 2,412 | $7.91 | $19,088 | 7,579 | −24.1% | 10b5-1 |
| Jun 10, 2026 SForm 4 → | Jun 11, 4:30 pm EDT | John Kenneth JenkinsDirector | 4,800 | $7.91 | $37,986 | 3,833 | −55.6% | 10b5-1 |
| Jun 2, 2026 PForm 4 → | Jun 3, 5:36 pm EDT | Nishant C SaxenaChief Business Officer | 13,500 | $7.50 | $101,219 | 75,300 | +21.8% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2026 AForm 4 → | Aug 17, 4:30 pm EDT | Leonardo Viana NicacioChief Medical Officer | 191,676 | — | — | 191,676 | — |